JSR Life Sciences spawns new venture fund; IL-2 biotech completes merger with trivia company subsidiary
There’s a new venture fund in town — this one led by a former Eli Lilly researcher with a seasoned resume that includes roles at Prudential Equity, BMO Capital Markets, and Edison Group.
JSR Life Sciences unveiled its new Life Sciences Corporate Venture Fund on Tuesday, with the goal of investing in “multiple deals within the next few years.” The initial focus will be emerging companies, according to a statement.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
